Drug Shortage Report for KADIAN
Report ID | 30923 |
Drug Identification Number | 02184451 |
Brand name | KADIAN |
Common or Proper name | KADIAN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | MORPHINE SULFATE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-04-03 |
Actual start date | 2018-03-29 |
Estimated end date | 2018-04-06 |
Actual end date | 2018-04-03 |
Shortage status | Resolved |
Updated date | 2018-04-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.